14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0001 $0.0001 Wednesday, 19th Apr 2023 GNCA stock ended at $0.0001. During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001.
90 days $0.0001 $0.0001
52 weeks $0.0001 $0.469

Historical Genocea Biosciences prices

Date Open High Low Close Volume
Oct 18, 2022 $0.0005 $0.0065 $0.0005 $0.0065 28 800
Oct 17, 2022 $0.0005 $0.0065 $0.0005 $0.0065 21 137
Oct 14, 2022 $0.0005 $0.0005 $0.0005 $0.0005 200
Oct 13, 2022 $0.0005 $0.0070 $0.0005 $0.0069 813
Oct 12, 2022 $0.0002 $0.0070 $0.0002 $0.0050 72 288
Oct 11, 2022 $0.0070 $0.0071 $0.0003 $0.0071 30 700
Oct 10, 2022 $0.0002 $0.0071 $0.0002 $0.0071 12 000
Oct 07, 2022 $0.0002 $0.0072 $0.0002 $0.0072 20 776
Oct 06, 2022 $0.0013 $0.0089 $0.0013 $0.0080 1 130 469
Oct 05, 2022 $0.0002 $0.0090 $0.0002 $0.0090 634 508
Oct 04, 2022 $0.0120 $0.0200 $0.0002 $0.0080 292 989
Oct 03, 2022 $0.0100 $0.0119 $0.0091 $0.0099 380 784
Sep 30, 2022 $0.0144 $0.0144 $0.0092 $0.0118 473 511
Sep 29, 2022 $0.0144 $0.0144 $0.0110 $0.0144 193 192
Sep 28, 2022 $0.0140 $0.0144 $0.0121 $0.0143 69 258
Sep 27, 2022 $0.0145 $0.0149 $0.0120 $0.0149 214 159
Sep 26, 2022 $0.0159 $0.0159 $0.0120 $0.0135 816 437
Sep 23, 2022 $0.0142 $0.0175 $0.0115 $0.0152 1 146 893
Sep 22, 2022 $0.0140 $0.0188 $0.0100 $0.0146 5 020 162
Sep 21, 2022 $0.0083 $0.0132 $0.0080 $0.0132 1 972 525
Sep 20, 2022 $0.0094 $0.0094 $0.0090 $0.0094 111 303
Sep 19, 2022 $0.0089 $0.0094 $0.0080 $0.0090 237 688
Sep 16, 2022 $0.0088 $0.0094 $0.0088 $0.0089 1 596 758
Sep 15, 2022 $0.0100 $0.0100 $0.0090 $0.0091 207 715
Sep 14, 2022 $0.0109 $0.0109 $0.0093 $0.0093 204 599
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT